AveXis Enters into Licensing Agreement with Genethon

World News: . []

CHICAGO and VRY France March 13 2018 GLOBE NEWSWIRE) -- AveXis Inc NASDAQAVXS and Genethon today announced they have entered into an exclusive worldwide license agreement for gene therapy delivery of AAV9 vector into the central nerv ous sys...

More news and information about AveXis, Inc.; Genethon

Published By:

Globe Newswire: 20:01 GMT Tuesday 13th March 2018

Published: .

Search for other references to "avexis" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us